Skip to main content

Table 2 Descriptive Statistics for Total FACT-EGFRI 18 Scale and Subscale Scores*

From: A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

  Mean
(SD)
Day 1 Day 8 Day 15 Day 22 Day 29 Day 36 Day 43 Day 71 Day 99 Day 127
Alopecia 92.4 93.7 93.5 93.6 91.5 90.1 88.3 82.8 79.9 75.0
(18.4) (16.5) (16.5) (17.5) (17.9) (18.0) (21.7) (26.6) (28.5) (30.6)
Dry skin 94.4 90.1 82.1 83.6 86.3 88.3 86.6 85.0 84.5 85.6
(8.7) (13.9) (21.7) (19.3) (16.9) (11.5) (12.6) (16.1) (13.4) (17.4)
Hypertrichosis 96.7 96.1 94.3 95.4 97.4 97.3 95.8 87.8 91.7 86.4
(11.1) (13.8) (17.4) (11.9) (8.6) (8.9) (12.4) (23.6) (22.4) (24.3)
Pain of skin 95.5 86.6 76.1 79.9 82.4 86.9 82.7 83.0 85.4 84.3
(11.4) (18.4) (23.7) (22.7) (20.0) (12.2) (16.9) (18.5) (16.6) (18.5)
Paronychia 96.2 95.2 92.5 87.7 86.8 88.0 82.4 77.2 80.2 75.8
(9.9) (10.3) (14.2) (20.6) (20.3) (16.4) (22.6) (25.3) (26.3) (24.6)
Pruritus 92.8 83.0 74 76.5 78.8 84.9 79.1 80.6 79.2 81.4
(15.1) (22.4) (24.2) (23.4) (21.4) (12.8) (18.3) (18.6) (19.4) (20.5)
Rash 94.9 89.5 80.7 82.8 85.5 88.5 85.2 84.4 84.3 84.7
(8.2) (13.9) (20.7) (18.9) (15.8) (9.7) (13.1) (16.6) (14.5) (16.9)
Total FACT- EGFRI 18 67.9 64.9 60.1 60.8 62.1 63.8 61.5 60.1 60.0 59.6
(5.3) (8.1) (11.8) (10.8) (9.0) (6.0) (8.6) (11.0) (9.9) (11.6)
  1. *Higher FACT-EGFRI scores reflect better health-related quality of life